|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 05, 2019 ) The global apheresis market was valued at USD 1.42 Billion in 2016. This market is expected to grow at a CAGR of 7.7% during the forecast period (2016–2021) to reach USD 2.06 Billion by 2021. The base year considered for the study is 2015 and the forecast for the market size is provided for the period between 2016 and 2021.
Some of the key factors driving the growth of the market include rising prevalence of diseases and growing number of trauma and injury cases, increasing demand for source plasma from biopharmaceutical companies, and the presence of a favorable reimbursement scenario for apheresis. Untapped emerging regions showcase new growth opportunities for this market. However, the growth of the market is restrained by the lack of awareness about apheresis and the high cost of these procedures.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950
In this report, the market is segmented on the basis of procedure, product type, technology, application, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. Based on product type, the market is segmented into devices and disposables. The disposables segment accounted for the largest share of the market in 2015; it is expected to grow at the highest CAGR during the forecast period. The increasing demand for disposables due to the rising number of therapeutic apheresis procedures being performed globally and the increasing trend towards apheresis blood collections are expected to drive the growth of this segment.
Based on technology, apheresis market is segmented into centrifugation and membrane separation technologies. The centrifugation technology segment accounted for the largest share of the global apheresis market in 2015. The large share of this segment can be attributed to the wide applications of centrifugation technology in the separation of plasma and cellular components of the blood.
“North America to hold the largest regional market share in 2022.”
In 2022, North America accounted for the largest share of the market, followed by Europe. The presence of established distribution channels, growing applications of apheresis products in plasma collection and fractionation, and rising number of hemophilic patients are driving the growth of the North American apheresis market. The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving healthcare infrastructure and growing economies in China and India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging APAC countries.
Some of the key players in this market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). These leading players primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions to help growth in the market.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
360Quadrants
Mr. Shelly Singh
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
